Convergence: FDA official offers insights on clinical holds, use of AI at CBER
Regulatory NewsJoanne S. Eglovitch
Biologics License Application (BLA)Biologics/ biosimilars/ vaccinesBiotechnologyCBERClinical TrialsCompliancePDUFAProject managementRegulatory Intelligence/PolicyUnited States